PainReform details NVIDIA program press release

PainReform Ltd., an Israel-based company, submitted a Form 6-K as a foreign private issuer.

Rhea-AI Filing Summary

PainReform Ltd., an Israel-based company, submitted a Form 6-K as a foreign private issuer. The report notes that on August 19, 2025, the company issued a press release titled “PainReform/DeepSolar Accepted into NVIDIA Connect Program.” The press release is furnished as Exhibit 99.1.

The filing is informational, formally placing this collaboration-related announcement into the company’s official U.S. disclosure record. No financial figures, deal terms, or operational metrics are included in this excerpt.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does PainReform Ltd. (PRFX) report in this Form 6-K?

PainReform Ltd. reports that it issued a press release titled “PainReform/DeepSolar Accepted into NVIDIA Connect Program.” The Form 6-K formally furnishes this press release as Exhibit 99.1 for U.S. investors and regulators.

What is the key announcement mentioned for PainReform Ltd. (PRFX)?

The key announcement is that PainReform/DeepSolar has been accepted into the NVIDIA Connect Program. This information comes from a press release dated August 19, 2025, which is attached to the Form 6-K as Exhibit 99.1.

When did PainReform Ltd. (PRFX) issue the related press release?

PainReform Ltd. issued the related press release on August 19, 2025. The Form 6-K specifies that this press release, titled “PainReform/DeepSolar Accepted into NVIDIA Connect Program,” is incorporated by reference as Exhibit 99.1.

Which exhibit is attached to PainReform Ltd.’s (PRFX) August 2025 Form 6-K?

The attached exhibit is 99.1, a press release dated August 19, 2025. The release is titled “PainReform/DeepSolar Accepted into NVIDIA Connect Program” and is incorporated by reference into the Form 6-K filing.

Where is PainReform Ltd. (PRFX) headquartered according to the Form 6-K?

PainReform Ltd. is headquartered at 65 Yigal Alon St., Tel Aviv 6744316, Israel. This address is listed as the principal executive offices in the Form 6-K filed as a report of a foreign private issuer.

Which annual report form does PainReform Ltd. (PRFX) use as a foreign issuer?

PainReform Ltd. files its annual reports under cover of Form 20-F. The Form 6-K indicates the relevant checkbox reference, confirming the company’s reporting format as a foreign private issuer.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 6-K: How Foreign Companies Report to the SEC →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 08/19/2025 - 08:45 AM EDT Learn about SEC filing dates

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

Form 6-K

Report of Foreign Private Issuer

Pursuant to Rule 13a-16 or 15d-16

of the Securities Exchange Act of 1934

For the month of August 2025

Commission File Number: 001-39481

PainReform Ltd.

(Translation of registrant’s name into English)

65 Yigal Alon St., Tel Aviv 6744316

Israel

(Address of principal executive offices)

Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.

Form 20-F ☒    Form 40-F ☐

On August 19, 2025, PainReform Ltd. issued a press release entitled “PainReform/DeepSolar Accepted into NVIDIA Connect Program”. A copy of the press release is attached hereto as Exhibit 99.1 and incorporated herein by reference.

Exhibit Index

Exhibit No.		Description
99.1		Press Release dated August 19, 2025.

 SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

Date: August 19, 2025	PAINREFORM LTD.
	By:	/s/ Ehud Geller
		Ehud Geller Executive Chairman of the Board and Interim Chief Executive Officer